DNASE2B
gene geneOn this page
Also known as DLAD
Summary
DNASE2B (deoxyribonuclease 2 beta, HGNC:28875) is a protein-coding gene on chromosome 1p31.1-p22.3, encoding Deoxyribonuclease-2-beta (Q8WZ79). Hydrolyzes DNA under acidic conditions.
The protein encoded by this gene shares considerable sequence similarity to, and is structurally related to DNase II. The latter is a well characterized endonuclease that catalyzes DNA hydrolysis in the absence of divalent cations at acidic pH. Unlike DNase II which is ubiquitously expressed, expression of this gene product is restricted to the salivary gland and lungs. The gene has been localized to chromosome 1p22.3 adjacent (and in opposite orientation) to the uricase pseudogene. Two transcript variants encoding different isoforms have been described for this gene.
Source: NCBI Gene 58511 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 36 total
- GTEx eGene: eQTL in 13 tissues, sQTL in 2 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.21 (unconstrained)
- MANE Select transcript:
NM_021233
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28875 |
| Approved symbol | DNASE2B |
| Name | deoxyribonuclease 2 beta |
| Location | 1p31.1-p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DLAD |
| Ensembl gene | ENSG00000137976 |
| Ensembl biotype | protein_coding |
| OMIM | 608057 |
| Entrez | 58511 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
MANE Select: ENST00000370665
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2
ENST00000370665, ENST00000370662, ENST00001145435
RefSeq mRNA: 2 — MANE Select: NM_021233
NM_021233, NM_058248
CCDS: CCDS44167, CCDS694
Canonical transcript exons
ENST00000370665 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001632362 | 84401901 | 84402078 |
| ENSE00001725172 | 84408437 | 84408518 |
| ENSE00001890136 | 84414528 | 84415018 |
| ENSE00002307921 | 84398484 | 84398689 |
| ENSE00003616455 | 84410838 | 84410999 |
| ENSE00003677606 | 84412349 | 84412546 |
Expression profiles
Bgee: expression breadth ubiquitous, 116 present calls, max score 85.06.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.2175 / max 550.4932, expressed in 127 samples.
Highest expression (Bgee): parotid gland, male germ line stem cell (sensu Vertebrata) in testis, saliva-secreting gland, minor salivary gland, gastrocnemius.
Genetic regulation across tissues (GTEx eQTL / sQTL)
DNASE2B is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 13 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
15 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Prostate | eqtl | 7.3e-30 | -0.62 | 1:84403370:A:T |
| Stomach | eqtl | 4.1e-26 | -0.41 | 1:84420612:T:A |
| Spleen | eqtl | 1.2e-08 | +0.42 | 1:84408934:C:T |
| Minor Salivary Gland | eqtl | 1.5e-08 | -0.36 | 1:84403370:A:T |
| Brain Nucleus accumbens basal ganglia | eqtl | 2.1e-08 | +1.35 | 1:84402249:C:T |
| Pituitary | eqtl | 7.6e-08 | -0.39 | 1:84408152:A:G |
| Pancreas | eqtl | 4.0e-06 | -0.37 | 1:84403370:A:T |
| Testis | eqtl | 2.5e-03 | -0.82 | 1:84308650:GCTTT:G |
| Artery Aorta | eqtl | 3.3e-03 | -0.25 | 1:84415988:C:T |
| Breast Mammary Tissue | eqtl | 8.2e-03 | -0.24 | 1:84403985:T:C |
| Muscle Skeletal | eqtl | 1.3e-02 | -0.13 | 1:84458496:A:T |
| Testis | sqtl | 1.7e-02 | +1.62 | 1:84382544:A:G |
| Brain Caudate basal ganglia | eqtl | 2.2e-02 | -0.27 | 1:84810967:T:C |
| Muscle Skeletal | sqtl | 2.2e-02 | +1.13 | 1:83978493:T:A |
| Brain Cerebellum | eqtl | 2.5e-02 | +0.41 | 1:84479751:T:C |
FANTOM5 promoters
5 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 3797 | 1.5777 | 109 |
| 3793 | 0.3970 | 63 |
| 3794 | 0.0990 | 44 |
| 3796 | 0.0796 | 37 |
| 3795 | 0.0642 | 30 |
Top tissues by expression
showing 100 of 253 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 85.06 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.71 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 70.84 | gold quality |
| minor salivary gland | UBERON:0001830 | 65.29 | gold quality |
| gastrocnemius | UBERON:0001388 | 62.14 | gold quality |
| mouth mucosa | UBERON:0003729 | 62.02 | gold quality |
| muscle of leg | UBERON:0001383 | 60.53 | gold quality |
| right lung | UBERON:0002167 | 59.64 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 59.00 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 57.73 | gold quality |
| muscle organ | UBERON:0001630 | 57.57 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 56.69 | gold quality |
| upper lobe of lung | UBERON:0008948 | 56.45 | gold quality |
| prostate gland | UBERON:0002367 | 54.49 | gold quality |
| nucleus accumbens | UBERON:0001882 | 53.92 | gold quality |
| tonsil | UBERON:0002372 | 53.73 | gold quality |
| rectum | UBERON:0001052 | 52.51 | gold quality |
| lymph node | UBERON:0000029 | 52.39 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 52.34 | gold quality |
| lung | UBERON:0002048 | 51.97 | gold quality |
| ileal mucosa | UBERON:0000331 | 51.72 | silver quality |
| deltoid | UBERON:0001476 | 50.73 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 50.60 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 50.54 | gold quality |
| muscle tissue | UBERON:0002385 | 50.24 | gold quality |
| gall bladder | UBERON:0002110 | 50.21 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 49.95 | gold quality |
| islet of Langerhans | UBERON:0000006 | 49.89 | gold quality |
| prefrontal cortex | UBERON:0000451 | 49.73 | gold quality |
| spinal cord | UBERON:0002240 | 49.70 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.35 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| body of stomach | UBERON:0001161 | 49.08 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.32 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 48.22 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| thymus | UBERON:0002370 | 48.15 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.00 | gold quality |
| visceral pleura | UBERON:0002401 | 47.99 | silver quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
| caudate nucleus | UBERON:0001873 | 47.61 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 47.45 | gold quality |
| kidney epithelium | UBERON:0004819 | 47.39 | gold quality |
| nephron tubule | UBERON:0001231 | 47.30 | gold quality |
| diaphragm | UBERON:0001103 | 47.05 | gold quality |
| gluteal muscle | UBERON:0002000 | 47.03 | gold quality |
| triceps brachii | UBERON:0001509 | 47.01 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 46.98 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 46.92 | gold quality |
| transverse colon | UBERON:0001157 | 46.65 | gold quality |
| stomach | UBERON:0000945 | 46.63 | gold quality |
| substantia nigra | UBERON:0002038 | 46.38 | gold quality |
| putamen | UBERON:0001874 | 46.37 | gold quality |
| frontal cortex | UBERON:0001870 | 46.30 | gold quality |
| telencephalon | UBERON:0001893 | 45.94 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 45.76 | gold quality |
| midbrain | UBERON:0001891 | 45.67 | gold quality |
| neocortex | UBERON:0001950 | 45.63 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 45.61 | gold quality |
| tibia | UBERON:0000979 | 45.57 | silver quality |
| hypothalamus | UBERON:0001898 | 45.53 | gold quality |
| fundus of stomach | UBERON:0001160 | 45.43 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 45.34 | gold quality |
| spleen | UBERON:0002106 | 45.26 | gold quality |
| cerebral cortex | UBERON:0000956 | 45.23 | gold quality |
| forebrain | UBERON:0001890 | 45.03 | gold quality |
| cingulate cortex | UBERON:0003027 | 44.83 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 44.81 | gold quality |
| right frontal lobe | UBERON:0002810 | 44.41 | gold quality |
| amygdala | UBERON:0001876 | 44.36 | gold quality |
| brain | UBERON:0000955 | 44.25 | gold quality |
| Ammon’s horn | UBERON:0001954 | 44.09 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 43.52 | gold quality |
| skin of hip | UBERON:0001554 | 43.47 | silver quality |
| squamous epithelium | UBERON:0006914 | 43.42 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| right adrenal gland | UBERON:0001233 | 43.19 | gold quality |
| stromal cell of endometrium | CL:0002255 | 42.98 | silver quality |
| epithelium of esophagus | UBERON:0001976 | 42.87 | gold quality |
| pancreatic ductal cell | CL:0002079 | 42.82 | silver quality |
| bone marrow cell | CL:0002092 | 42.82 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 42.75 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 42.70 | gold quality |
| bronchus | UBERON:0002185 | 42.58 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| granulocyte | CL:0000094 | 42.21 | silver quality |
| temporal lobe | UBERON:0001871 | 42.11 | gold quality |
| cartilage tissue | UBERON:0002418 | 42.04 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.41 |
HPA expression
RNA tissue specificity: Tissue enriched
51 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Salivary gland | tissue | 160.3 |
| Prostate | tissue | 6.3 |
| Lung | tissue | 2.3 |
| Nucleus accumbens | tissue | 0.9 |
| Pancreas | tissue | 0.7 |
| Lymph node | tissue | 0.6 |
| Skeletal muscle | tissue | 0.6 |
| Rectum | tissue | 0.5 |
| Basal ganglia | tissue | 0.5 |
| Postcentral gyrus | tissue | 0.5 |
| Breast | tissue | 0.4 |
| Testis | tissue | 0.4 |
| Colon | tissue | 0.4 |
| Putamen | tissue | 0.4 |
| Hippocampal formation | tissue | 0.4 |
| Ventral forebrain | tissue | 0.4 |
| Pituitary gland | tissue | 0.3 |
| Stomach 1 | tissue | 0.3 |
| Amygdala | tissue | 0.3 |
| Liver | tissue | 0.3 |
| Gallbladder | tissue | 0.3 |
| Locus coeruleus | tissue | 0.3 |
| Hippocampus | tissue | 0.3 |
| Entorhinal cortex | tissue | 0.3 |
| Septum | tissue | 0.3 |
| Cervix | tissue | 0.2 |
| Cerebral cortex | tissue | 0.2 |
| Pons | tissue | 0.2 |
| Adipose tissue | tissue | 0.2 |
| Motor cortex | tissue | 0.2 |
| Tongue | tissue | 0.2 |
| Hypothalamus | tissue | 0.2 |
| Spleen | tissue | 0.2 |
| Thymus | tissue | 0.2 |
| Retrosplenial and cingulate cortex | tissue | 0.2 |
| Retrosplenial cortex | tissue | 0.2 |
| Temporal cortex | tissue | 0.2 |
| Insular cortex | tissue | 0.2 |
| Prefrontal cortex | tissue | 0.1 |
| Midbrain | tissue | 0.1 |
| Medulla oblongata | tissue | 0.1 |
| Thalamus | tissue | 0.1 |
| Superior colliculi | tissue | 0.1 |
| Cerebellum | tissue | 0.1 |
| Substantia nigra | tissue | 0.1 |
| Thyroid gland | tissue | 0.1 |
| Spinal cord | tissue | 0.1 |
| Corpus callosum | tissue | 0.1 |
| Tonsil | tissue | 0.1 |
| Periaqueductal gray | tissue | 0.1 |
| Occipital cortex | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 188; highest nTPM — Arcuate nucleus (1.7), Lateral funiculus (white matter) (1.4), Parieto-temporal junction (white matter) (1.1), Corpus callosum, genu (white matter) (0.9), Corpus callosum, splenium (white matter) (0.9).
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): HSF4, TBX15
miRNA regulators (miRDB)
Targeting DNASE2B by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
17 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4650-5P | 99.98 | 64.69 | 999 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-657 | 99.48 | 66.02 | 848 |
| HSA-MIR-142-5P | 99.48 | 70.92 | 2416 |
| HSA-MIR-5590-3P | 99.48 | 70.91 | 2429 |
| HSA-MIR-1245B-5P | 98.88 | 66.55 | 576 |
| HSA-MIR-3142 | 98.88 | 66.09 | 529 |
| HSA-MIR-4712-3P | 98.52 | 65.39 | 822 |
| HSA-MIR-3689A-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689B-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689E | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689F | 98.35 | 70.08 | 1052 |
| HSA-MIR-3665 | 97.73 | 65.08 | 975 |
| HSA-MIR-3667-5P | 97.16 | 64.87 | 591 |
Functional genomics
gnomAD constraint: pLI 2.43e-14, LOEUF 1.21, missense Z 0.677 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000370665 — one region, missense o/e 0.95.
Literature-anchored findings (GeneRIF, showing 3)
- gene lie head-to-head with the urate oxidase gene (PMID:11700027)
- These data identify DNase 2 as the predominant DNase on the mammalian skin surface and indicate that its activity is primarily targeted to exogenous DNA. (PMID:21390259)
- HSF4 exerts its function on lens differentiation via positive regulation of DLAD expression. (PMID:23507146)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dnase2b | ENSDARG00000077918 |
| mus_musculus | Dnase2b | ENSMUSG00000028185 |
| rattus_norvegicus | Dnase2b | ENSRNOG00000016262 |
| drosophila_melanogaster | DNaseII | FBGN0000477 |
| caenorhabditis_elegans | WBGENE00000799 | |
| caenorhabditis_elegans | WBGENE00003828 | |
| caenorhabditis_elegans | WBGENE00007056 |
Paralogs (1): DNASE2 (ENSG00000105612)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1913283) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 5 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| decreased bone mineral density | 1 |
| cataract | 1 |
| increased circulating HDL cholesterol level | 1 |
| abnormal vision | 1 |
| abnormal eye electrophysiology | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Sus scrofa | O62855 | 82.6% | Diamond |
| Bos taurus | P56541 | 82.6% | Diamond |
| Acanthaster planci | Q75WF2 | 40.9% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| LINC01461 | ncRNA | 103695366 |
| CTBS | protein-coding | 1486 |
| GNG5 | protein-coding | 2787 |
| RPF1 | protein-coding | 80135 |
| SPATA1 | protein-coding | 100505741 |
| SAMD13 | protein-coding | 148418 |
Protein
Protein identifiers
Deoxyribonuclease-2-beta — Q8WZ79 (reviewed: Q8WZ79)
Alternative names: DNase II-like acid DNase, DNase2-like acid DNase, Deoxyribonuclease II beta, Endonuclease DLAD
All UniProt accessions (1): Q8WZ79
UniProt curated annotations — full annotation on UniProt →
Function. Hydrolyzes DNA under acidic conditions. Does not require divalent cations for activity. Participates in the degradation of nuclear DNA during lens cell differentiation.
Subcellular location. Lysosome.
Tissue specificity. Highly expressed in the eye lens and in salivary gland. Detected at lower levels in lung, prostate and lymph node. Isoform 2 is lung specific.
Similarity. Belongs to the DNase II family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WZ79-1 | 1 | yes |
| Q8WZ79-2 | 2 |
RefSeq proteins (2): NP_067056, NP_490649 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004947 | DNase_II | Family |
Pfam: PF03265
Enzyme classification (BRENDA)
- EC 3.1.22.1 — deoxyribonuclease II (BRENDA: 30 organisms, 69 substrates, 60 inhibitors, 6 Km, 6 kcat entries)
Substrate kinetics (BRENDA)
1 substrates with measured Km, best-characterized 1. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| SUPERCOILED PLASMID DNA | — | 6 |
UniProt features (10 total): glycosylation site 4, sequence variant 3, signal peptide 1, chain 1, splice variant 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WZ79-F1 | 91.22 | 0.82 |
Human Protein Atlas
Protein class: Enzymes, ENZYME proteins, Hydrolases, Predicted intracellular proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at transcript level
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (4)
| Type | Positions |
|---|---|
| N-linked (glcnac…) asparagine | 81, 103, 119, 278 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 85 (showing top):
GOMF_ENDONUCLEASE_ACTIVITY, HNF3ALPHA_Q6, GOMF_NUCLEASE_ACTIVITY, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, KEGG_LYSOSOME, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, GOBP_DNA_CATABOLIC_PROCESS, TGCTGAY_UNKNOWN, INGRAM_SHH_TARGETS_UP, RYTTCCTG_ETS2_B, YY1_01, AML1_01, GOBP_APOPTOTIC_DNA_FRAGMENTATION, GOBP_EXECUTION_PHASE_OF_APOPTOSIS, NKX3A_01
GO Biological Process (2): apoptotic DNA fragmentation (GO:0006309), DNA metabolic process (GO:0006259)
GO Molecular Function (5): deoxyribonuclease II activity (GO:0004531), nuclease activity (GO:0004518), endonuclease activity (GO:0004519), DNA endonuclease activity (GO:0004520), hydrolase activity (GO:0016787)
GO Cellular Component (3): extracellular region (GO:0005576), lysosome (GO:0005764), cytoplasm (GO:0005737)
GO top-level categories
12 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| DNA catabolic process | 1 |
| apoptotic nuclear changes | 1 |
| nucleic acid metabolic process | 1 |
| DNA endonuclease activity, producing 3’-phosphomonoesters | 1 |
| catalytic activity, acting on a nucleic acid | 1 |
| nuclease activity | 1 |
| endonuclease activity | 1 |
| DNA nuclease activity | 1 |
| catalytic activity | 1 |
| lytic vacuole | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
showing 15 of 639 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DNASE2B | DNASE1L1 | P49184 | 632 |
| DNASE2B | BFSP1 | Q12934 | 505 |
| DNASE2B | CRYGS | P22914 | 500 |
| DNASE2B | DNASE1L2 | Q92874 | 478 |
| DNASE2B | SOWAHA | Q2M3V2 | 464 |
| DNASE2B | CRYGA | P11844 | 462 |
| DNASE2B | LENEP | Q9Y5L5 | 452 |
| DNASE2B | LGSN | Q5TDP6 | 445 |
| DNASE2B | ENTREP1 | Q15884 | 442 |
| DNASE2B | FOXE3 | Q13461 | 440 |
| DNASE2B | TDRD7 | Q8NHU6 | 437 |
| DNASE2B | CRYBA2 | P53672 | 434 |
| DNASE2B | BFSP2 | Q13515 | 424 |
| DNASE2B | HSF4 | Q9ULV5 | 418 |
| DNASE2B | GRIFIN | A4D1Z8 | 408 |
IntAct
Human interaction partners of DNASE2B in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
3 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| ARSA | association | 0.530 | 1 |
| HEXA | association | 0.350 | 1 |
| LRP5 | association | 0.350 | 1 |
BioGRID (79 interactions; top human partners by supporting records): FUT11 (Affinity Capture-MS; 3 records), GALNS (Affinity Capture-MS; 3 records), GPR98 (Affinity Capture-MS; 3 records), IL17RA (Affinity Capture-MS; 3 records), PPP2R5D (Affinity Capture-MS; 3 records), PPP2R5E (Affinity Capture-MS; 3 records), SUCO (Affinity Capture-MS; 3 records), TMEM132A (Affinity Capture-MS; 3 records), TOR3A (Affinity Capture-MS; 3 records), TRAPPC2 (Affinity Capture-MS; 3 records), WIPI1 (Affinity Capture-MS; 3 records), YTHDF1 (Affinity Capture-MS; 3 records), AMD1 (Affinity Capture-MS; 2 records), ARSA (Affinity Capture-MS; 2 records), CERCAM (Affinity Capture-MS; 2 records)
SIGNOR signaling
1 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| HSF4 | “up-regulates quantity by expression” | DNASE2B | “transcriptional regulation” |
Disease & clinical
Genetic variants
Variant evidence for DNASE2B: 36 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 35 |
| Likely benign | 0 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 19 predictions of 520):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 1:84398592 | donor_gain | 0.9900 | |
| 1:84412334 | acceptor_gain | 0.9900 | |
| 1:84412341 | acceptor_gain | 0.9900 | |
| 1:84412502 | donor_gain | 0.9900 | |
| 1:84414520 | acceptor_gain | 0.9900 | |
| 1:84412347–84412348 | acceptor_loss | 0.9800 | 5 |
| 1:84412547–84412548 | donor_loss | 0.9800 | 6 |
| 1:84398538 | donor_gain | 0.9700 | |
| 1:84398584 | donor_gain | 0.9700 | |
| 1:84410996 | donor_gain | 0.9700 |
AlphaMissense
516 missense substitutions predicted likely pathogenic (of 2,363 scored), across 134 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D304 | 8 | 0.921 | 0.968 |
| H305 | 8 | 0.870 | 0.931 |
| D112 | 8 | 0.848 | 0.921 |
| H126 | 8 | 0.841 | 0.927 |
| D324 | 8 | 0.833 | 0.918 |
| D249 | 8 | 0.809 | 0.911 |
| C171 | 7 | 0.944 | 0.974 |
| C340 | 7 | 0.942 | 0.974 |
| C321 | 7 | 0.939 | 0.972 |
| F148 | 7 | 0.928 | 0.975 |
| C32 | 7 | 0.919 | 0.957 |
| C279 | 7 | 0.899 | 0.943 |
| W268 | 7 | 0.898 | 0.968 |
| W308 | 7 | 0.892 | 0.983 |
| N326 | 7 | 0.877 | 0.966 |
| F43 | 7 | 0.861 | 0.968 |
| C360 | 7 | 0.845 | 0.896 |
| N111 | 7 | 0.811 | 0.966 |
| D41 | 7 | 0.671 | 0.791 |
| K128 | 6 | 0.942 | 0.991 |
HPA cancer prognostics
RNA cancer specificity: Group enriched (Prostate Adenocarcinoma, Skin Cutaneous Melanoma)
Disease associations
OMIM: gene MIM:608057 | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST001325_9 | Response to hepatitis C treatment | 7e-6 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression | 2 |
| bisphenol A | decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Dihydrotestosterone | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): chronic hepatitis C virus infection